The Study
Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut
This study tried a new idea in test tubes and mice, but we don’t know if it was done fairly or carefully enough to trust the results. So we can’t say for sure that it works or why.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
Scientists made harmless E. coli bacteria wear a special shield (ClbS) that catches a cancer-causing poison (colibactin) made by other bad bacteria in the gut.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 540 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this could lead to a new way to prevent colon cancer caused by gut bacteria, especially in people with inflammation.
- 2The shielded bacteria cut DNA damage by 60% in human cells, stopped it completely with more shield, reduced tumors by 50–70% in mice, and cut bad bacteria in poop by 30 times.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Nature microbiology
Year
2025
Authors
Shaobo Yang, Zongqi Wang, Chengyuan Fang, Mengdi Yang, Saleh Khawaled, S. Bonanno, Neel S. Joshi, Yun Wei, Ke Zhang, Valeria Márquez-Pellegrin, Ming Guan, Songqi Zhang, Anna Clara Bader, Ningyuan Ye, Amber E Haley, Michael K. Dame, J. Spence, Xuesong He, James G. Fox, Ömer H. Yilmaz, Yatrik M. Shah, R. Romee, Jiahe Li
Related Content
Claims (6)
Certain strains of Escherichia coli that produce colibactin cause distinct double-strand breaks in the DNA of cells lining the colon, leading to characteristic mutation patterns known as SBS88 and ID18.
A genetically modified strain of E. coli bacteria, designed to display a specific protein, reduces signs of intestinal damage and inflammation in mice with chemically induced colitis, as shown by improved tissue scores and increased mucus-producing cells.
Engineered bacteria with ClbS protein on their surface reduce DNA damage caused by a bacterial toxin in human colon tissue models and colorectal cancer cells.
Engineered bacteria displaying a specific protein called ClbS can reduce DNA damage caused by a toxin produced by other bacteria, with higher levels of the protein nearly eliminating the damage in human cells grown in the lab.
A genetically modified strain of E. coli bacteria, designed to produce a specific protein, reduces tumor formation by half to two-thirds in mice with intestinal inflammation and a genetic predisposition to colon cancer, when given alongside a cancer-promoting bacterial strain.
A genetically modified strain of E. coli, designed to produce a protein that neutralizes colibactin, significantly lowers the levels of a harmful E. coli strain in the intestines of mice.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.